The AZAdvances Health Innovation Showcase featured an exciting lineup of Arizona-based innovators revolutionizing the future of healthcare through technologies, data solutions, and patient-focused strategies. During the event, numerous companies across diagnostics, digital health, therapeutics, and care delivery presented their ideas and visions for the future.Continue reading
GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery and development, and researchers from the University of California, Irvine (UCI) today announced the publication of a joint study in the Proceedings of the National Academy of Sciences (PNAS). The peer-reviewed paper validates a novel drug candidate, GATC-1021, which was identified using GATC Health’s Operon™ AI platform to more precisely target the specific neurological dysregulations found in individuals with Opioid Use Disorder (OUD).Continue reading
Precision Epigenomics focuses on addressing cancer by targeting epigenetic changes (i.e., DNA methylation) that drive tumor development, progression, and treatment resistance. While genetic mutations have long been a focus in oncology, epigenetic dysregulation plays a critical role in how cancer cells behave, adapt, and evade therapy. Their work centers on using their understanding of DNA methylation to develop new and innovative diagnostic tests to detect cancer earlier.Continue reading
TEMPE, Ariz., April 2, 2026 /PRNewswire/ — With more than 40 years of diverse health care experience, Todd LaPorte has led HonorHealth through growth, innovation, and expanded access to high-quality care across the Phoenix metropolitan area. As CEO since 2017, LaPorte oversees an integrated health system that includes nine acute-care hospitals, hundreds of outpatient facilities, a research institute, a behavioral health hospital, a rehabilitation hospital, and a wide range of community services addressing social determinants of health and military preparedness.Continue reading